Want to join the conversation?
$RHI expects revenue of $1.335-1.395Bil and EPS of $0.68-0.74 in 3Q16. The midpoint of the guidance implies YoverY revenue growth of 4% on a reported basis and 4.6% adjusted for billing days and currency, including Protiviti; and negative EPS growth of 3%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?